Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchogenic carcinoma after solid organ transplantation.

Marc de Perrot1, Dennis A Wigle, Andrew F Pierre

  • 1Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

The Annals of Thoracic Surgery
|February 28, 2003
PubMed
Summary

The risk of lung cancer after organ transplantation is low, primarily affecting smokers. However, lung cancer can be transmitted from donor lungs, highlighting the need for careful donor lung screening.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal cancer recurrence after multimodality therapy: analysis of patterns and implications on long-term survival.

Journal of thoracic disease·2026
Same author

Robotic transgastric local resection of endoscopically unresectable gastroesophageal junction benign/low-grade lesions.

JTCVS techniques·2026
Same author

The additive effect of high-risk tumor features on long-term survival and recurrence in pathologic stage I non-small cell lung cancer.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Pulmonary mucormycosis: outcomes by treatment modality and underlying comorbidity.

The Annals of thoracic surgery·2026
Same author

FDG-PET/CT SUVmax Predicts Recurrence Risk of Resected Pleuropulmonary Solitary Fibrous Tumors.

JTO clinical and research reports·2026
Same author

Risk factors and survival associated with lung cancer recurrence after curative-intent surgery: beyond TNM pathological staging.

Journal of thoracic disease·2025

Area of Science:

  • Oncology
  • Transplantation Medicine
  • Pulmonary Medicine

Background:

  • Malignancy risk is elevated post-solid organ transplantation.
  • Bronchogenic carcinoma risk in transplant recipients remains understudied.

Purpose of the Study:

  • To assess the incidence and characteristics of bronchogenic carcinoma in solid organ transplant recipients.
  • To identify risk factors and potential transmission routes of lung cancer in this population.

Main Methods:

  • Retrospective cohort study of 3,374 solid organ transplant recipients (kidney, liver, heart, lung) between 1985-2000.
  • Analysis of patient demographics, transplant type, smoking history, and cancer diagnosis.
  • Tumor staging and genotyping for a lung transplant recipient case.

Related Experiment Videos

Main Results:

  • Nine patients (0.3%) developed bronchogenic carcinoma post-transplant.
  • Most cases occurred in recipients with a smoking history; one case was linked to donor lung transmission.
  • Tumor stages varied, with some patients undergoing successful resection and showing no recurrence.

Conclusions:

  • Bronchogenic carcinoma risk is low in transplant recipients, mainly associated with smoking.
  • Donor lung transmission of cancer is a rare but significant risk, necessitating thorough donor lung evaluation.
  • Enhanced screening of donor lungs is crucial, especially with evolving donor criteria, to prevent cancer transmission.